(Q38780717)

https://doi.org/10.1016/j.biopha.2023.115374

6 September 2017

1 reference

29 December 2023

title

miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway (English)

1 reference

6 September 2017

main subject

neoplastic stem cells

1 reference

Bailong Li

1

1 reference

6 September 2017

Ying Lu

2

1 reference

6 September 2017

Honghai Wang

3

1 reference

6 September 2017

Xiaocui Han

4

1 reference

6 September 2017

Jun Mao

5

1 reference

6 September 2017

Jiazhi Li

6

1 reference

6 September 2017

Lihui Yu

7

1 reference

6 September 2017

Bo Wang

8

1 reference

6 September 2017

Shujun Fan

9

1 reference

6 September 2017

Xiaotang Yu

10

1 reference

6 September 2017

Bo Song

11

1 reference

6 September 2017

publication date

17 February 2016

1 reference

Biomedicine and Pharmacotherapy

6 September 2017

published in

1 reference

6 September 2017

volume

79

1 reference

6 September 2017

page(s)

93-101

1 reference

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

6 September 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.CCR.2009.10.014

Anti-microRNA-222 (anti-miR-222) and -181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal.

1 reference

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M111.270926

COCI

reference URL

miR-221/222 control luminal breast cancer tumor progression by regulating different targets.

30 December 2023

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

miR-181a and miR-630 regulate cisplatin-induced cancer cell death

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Stem Cells and Cancer: Two Faces of Eve

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

MicroRNAs in human cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Cancer statistics, 2013

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

MicroRNA profiling in cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Natural inhibitors of PI3K/AKT signaling in breast cancer: emphasis on newly-discovered molecular mechanisms of action.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

miR221/222 in cancer: their role in tumor progression and response to therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

microRNAs in cancer management.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Cancer stem cells: an evolving concept

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2016.01.045

Identifiers

DOI

10.1016/J.BIOPHA.2016.01.045

1 reference

6 September 2017

1 reference